Tokyo, Japan

Tatsuaki Morokata

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Tatsuaki Morokata: Innovator in Pharmaceutical Compounds

Introduction: Tatsuaki Morokata is a prominent inventor hailing from Tokyo, Japan. With a focus on groundbreaking pharmaceutical innovations, he has been instrumental in developing compounds that have the potential to address critical health issues. His work is particularly notable for its contributions to preventing and treating diseases linked to lymphocyte infiltration and abnormal cell proliferation.

Latest Patents: Morokata holds a total of three patents, with his latest inventions focusing on two significant compounds. The first is a 2H-chromene compound and its derivatives, which exhibit excellent S1P agonist action. This compound is particularly useful as an active ingredient for agents aimed at preventing and treating diseases induced by undesirable lymphocyte infiltration and abnormal cellular proliferation. The second patent focuses on a hetero compound, designed as an active ingredient for prevention and treatment applications related to organ transplantation rejection, autoimmune diseases, and other serious conditions. This product also showcases outstanding S1P agonist activity, highlighting Morokata's commitment to addressing complex medical challenges.

Career Highlights: Morokata is associated with Astellas Pharma GmbH, a leading global pharmaceutical company. His work is characterized by a labored commitment to scientific research and innovation, directly impacting the field of pharmacology and therapeutic development. Throughout his career, he has shown dedication to devising effective solutions for various health concerns.

Collaborations: In the pursuit of innovation, Morokata has collaborated with notable colleagues such as Hironori Harada and Kazuyuki Hattori. This collaboration emphasizes the team-oriented approach often seen in significant advancements within the pharmaceutical industry, showcasing the importance of diverse expertise in fostering innovation.

Conclusion: Tatsuaki Morokata's inventive spirit and commitment to breakthroughs in pharmaceutical compounds mark him as a significant contributor to medical science. His innovative patents not only highlight his skill as an inventor but also underscore the potential for developing new treatments for challenging health issues. As he continues his work at Astellas Pharma GmbH, the medical field anticipates further contributions from this dedicated inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…